Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Biomedical Inc.

Division of Sumitomo Chemical Co.
www.bostonbiomedical.com

Latest From Eiken Chemical Co. Ltd.

UK NICE Recommends FITs As 'More Accurate' Than Guaiac-Based Fecal Tests

A new draft guidance from the National Institute for Health and Care Excellence (NICE) recommends the NHS use fecal immunochemical tests (FITs), instead of guaiac-based tests, for detecting gastrointestinal bleeding associated with bowel cancer.

Health Technology Assessment In Vitro Diagnostics

HiberGene's Under-An-Hour Meningitis Test Hits Europe

Emerging Irish IVD company HiberGene Diagnostics has just CE marked HG Meningococcus, a molecular diagnostic test for bacterial meningitis that can detect Neisseria meningitidis in cerebrospinal fluid, whole blood and via a nasopharyngeal swab in less than one hour. The company is set to launch the test in Europe with distribution agreements in place for Ireland, Germany, Austria, Spain, Turkey and Poland.

Medical Device Europe

HiberGene Diagnostics Ltd.

Dublin-based start-up HiberGene Diagnostics Ltd. aims to create rapid, accurate, and simple diagnostic tests for infectious diseases based on LAMP (loop-mediated isothermal amplification) technology, which uses nucleic acid amplification to identify target genes.

Medical Device

Recent Warning Letter Close-Outs

Six quality-related FDA close-out letters were released from Aug. 12 through Sept. 11.

Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Sumitomo Chemical Co.
  • Senior Management
  • Patricia S Andrews, CEO
    David S Leggett, PhD, VP, COO
  • Contact Info
  • Boston Biomedical Inc.
    Phone: (781) 278-0900
    333 Providence Hwy.
    Norwood, MA 02062
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register